Company
SINOVAC at Glance
Our History
Social Responsibilities
Innovation
Platform
Pipeline
Scientific Achievements
Partners
— Research Institute
— Universities
— Medical Institutions
— Companies
Products
Vaccines
International Business
Quality Management System
Product Consultation
Adverse Event Report
News
Press Releases
Updates and Statements
Media Asset Library
Investors
Financial Reports
SEC Filings
Careers
Our Talent
中文
EN
Contact Us
Company
SINOVAC at Glance
Our History
Social Responsibilities
News
Press Releases
Updates and Statements
Media Asset Library
— Logo
— Vaccines
Innovation
Platform
Pipeline
Scientific Achievements
Partners
— Research Institute
— Universities
— Medical Institutions
— Companies
Products
Vaccines
International Business
Quality Management System
Product Consultation
Adverse Event Report
Investors
Financial Reports
— YEAR 2024
— YEAR 2023
— YEAR 2021
— YEAR 2022
— YEAR 2020
— YEAR 2019
— YEAR 2018
— YEAR 2017
— YEAR 2016
— YEAR 2015
— YEAR 2014
— YEAR 2013
— YEAR 2012
— YEAR 2011
— YEAR 2010
— YEAR 2009
— YEAR 2008
— YEAR 2007
— YEAR 2006
— YEAR 2005
— YEAR 2004
— YEAR 2003
SEC Filings
— YEAR 2025
— YEAR 2024
— YEAR 2023
— YEAR 2022
— YEAR 2021
— YEAR 2020
— YEAR 2019
— YEAR 2018
— YEAR 2017
— YEAR 2016
— YEAR 2015
— YEAR 2014
— YEAR 2013
— YEAR 2012
— YEAR 2011
— YEAR 2010
— YEAR 2009
Careers
Our Talent
Contact Us
联系我们
当前地点：
EN
选择地点：
中文
EN
Home
Company
SINOVAC at Glance
Our History
Social Responsibilities
News
Press Releases
Updates and Statements
Media Asset Library
Innovation
Platform
Pipeline
Scientific Achievements
Partners
Products
Vaccines
International Business
Quality Management System
Product Consultation
Adverse Event Report
Investors
Financial Reports
SEC Filings
Careers
Our Talent
Contact Us
中文
EN
SEC Filings
SEC-generated letter
2010-07-13 17:01:15
链接二 ：
../investors/file/File/sec/2010/0713.UPLOAD.pdf
立即下载
Previous
: Report of foreign issuer [Rules 13a-16 and 15d-16]
Next
: Report of foreign issuer [Rules 13a-16 and 15d-16]
© SINOVAC All rights reserved
EN
